158 related articles for article (PubMed ID: 3539124)
41. [Concept of class in relation to first-generation cephalosporins].
De Toffoli A; Fantin B; Vechiet D
Quad Sclavo Diagn; 1984 Jun; 20(2):181-6. PubMed ID: 6441962
[TBL] [Abstract][Full Text] [Related]
42. Inhibitory and bactericidal activity of cefpirome and cefotaxime against blood culture isolates.
Ansorg R; Primavesi CA; von Recklinghausen G
Chemotherapy; 1990; 36(1):24-8. PubMed ID: 2106417
[TBL] [Abstract][Full Text] [Related]
43. Enhancing effect of serum ultrafiltrate on the activity of cephalosporins against gram-negative bacilli.
Leggett JE; Craig WA
Antimicrob Agents Chemother; 1989 Jan; 33(1):35-40. PubMed ID: 2496656
[TBL] [Abstract][Full Text] [Related]
44. [Antibacterial activity of cephem antibiotics against isolates from clinical specimens at the Yokohama City University Hospital].
Kaminaga Y; Sato Y; Hanada K; Ito A
Jpn J Antibiot; 1986 Oct; 39(10):2547-56. PubMed ID: 3543429
[TBL] [Abstract][Full Text] [Related]
45. Comparative evaluation of the diffusion of tobramycin and cefotaxime out of antibiotic-impregnated polymethylmethacrylate beads.
Wilson KJ; Cierny G; Adams KR; Mader JT
J Orthop Res; 1988; 6(2):279-86. PubMed ID: 3278081
[TBL] [Abstract][Full Text] [Related]
46. [Effect of proteolytic enzymes on the antimicrobial activity of antibiotics].
Maloman EN; Syrbu VT; Lupashku BK
Antibiotiki; 1975 Jun; 20(7):613-7. PubMed ID: 773293
[TBL] [Abstract][Full Text] [Related]
47. Post-antibiotic effects of cefdinir on Escherichia coli, Klebsiella pneumoniae, Staphylococcus aureus and Streptococcus pyrogenes.
Howard BM; Pinney RJ; Smith JT
Chemotherapy; 1994; 40(4):232-8. PubMed ID: 8082410
[TBL] [Abstract][Full Text] [Related]
48. Effect of pH upon the activity of cefoxitin.
Tobe K; Nishino T; Hirai Y; Nakazawa S
J Antibiot (Tokyo); 1977 Dec; 30(12):1123-6. PubMed ID: 23373
[No Abstract] [Full Text] [Related]
49. Serum bactericidal activity of moxalactam and cefotaxime with and without tobramycin against Pseudomonas aeruginosa and Staphylococcus aureus.
Lagast H; Zinner SH; Klastersky J
Antimicrob Agents Chemother; 1981 Oct; 20(4):539-41. PubMed ID: 6282198
[TBL] [Abstract][Full Text] [Related]
50. [In-vitro sensitivity of Klebsiella-Enterobacter strains against cefazolin (author's transl)].
Krasemann C; Peckelsen C
Dtsch Med Wochenschr; 1977 Jan; 102(3):87-90. PubMed ID: 832585
[TBL] [Abstract][Full Text] [Related]
51. Bactericidal activity of cefazolin, cefoxitin, and cefmetazole against Escherichia coli and Klebsiella pneumoniae.
Goto S; Sakamoto H; Ogawa M; Tsuji A; Kuwahara S
Chemotherapy; 1982; 28(1):18-25. PubMed ID: 7035088
[TBL] [Abstract][Full Text] [Related]
52. Antimicrobial activity of ciprofloxacin against Pseudomonas aeruginosa, Escherichia coli, and Staphylococcus aureus determined by the killing curve method: antibiotic comparisons and synergistic interactions.
Chalkley LJ; Koornhof HJ
Antimicrob Agents Chemother; 1985 Aug; 28(2):331-42. PubMed ID: 2939797
[TBL] [Abstract][Full Text] [Related]
53. [Timed bacteriostatic and bactericidal activities of latamoxef against clinical strains of gram-negative bacteria].
Masuda G; Negishi M; Young C; Mukaiyama T; Hanai N; Uchikawa S; Thoma T; Yamazaki E
Jpn J Antibiot; 1983 Jan; 36(1):16-21. PubMed ID: 6221128
[No Abstract] [Full Text] [Related]
54. Serum bactericidal activity against Klebsiella pneumoniae in volunteers receiving increasing doses of tobramycin with or without cefamandole.
Pascual-Lopez A; Lagast H; Klastersky J
Int J Clin Pharmacol Res; 1987; 7(1):45-9. PubMed ID: 3294615
[TBL] [Abstract][Full Text] [Related]
55. Effect of concentration on bactericidal activity of cefotaxime.
Shah PM; Troche G; Stille W
J Antimicrob Chemother; 1979 Jul; 5(4):419-22. PubMed ID: 114510
[No Abstract] [Full Text] [Related]
56. Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard, and E test.
White RL; Burgess DS; Manduru M; Bosso JA
Antimicrob Agents Chemother; 1996 Aug; 40(8):1914-8. PubMed ID: 8843303
[TBL] [Abstract][Full Text] [Related]
57. [An investigation into the influence of human serum on the in-vitro activity of various cephalosporins (author's transl)].
Ratschow R; Krone JR
Infection; 1977; 5(4):236-41. PubMed ID: 340385
[TBL] [Abstract][Full Text] [Related]
58. Decreased bactericidal activity during the period of the postantibiotic effect.
Gudmundsson S; Vogelman B; Craig WA
J Antimicrob Chemother; 1994 Dec; 34(6):921-30. PubMed ID: 7730235
[TBL] [Abstract][Full Text] [Related]
59. Validation of Etest for seven antimicrobial agents using regulatory criteria for the assessment of antimicrobial susceptibility devices.
Biedenbach DJ; Schermer IH; Jones RN
Diagn Microbiol Infect Dis; 1997; 27(1-2):1-5. PubMed ID: 9127098
[TBL] [Abstract][Full Text] [Related]
60. Comparative plasma bactericidal activity of cephapirin and cefazolin.
Hottendorf GH; Price KE; Van Harken DR
Curr Ther Res Clin Exp; 1975 Aug; 18(2):364-70. PubMed ID: 809250
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
